Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Medicus Pharma Ltd. - Common Stock
(NQ:
MDCX
)
1.580
+0.060 (+3.95%)
Streaming Delayed Price
Updated: 10:51 AM EST, Dec 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
148,927
Open
1.520
Bid (Size)
1.570 (100)
Ask (Size)
1.580 (3,600)
Prev. Close
1.520
Today's Range
1.520 - 1.600
52wk Range
1.490 - 8.940
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform
December 22, 2025
Via
ACCESS Newswire
Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
December 15, 2025
From
Medicus Pharma Ltd
Via
GlobeNewswire
Performance
YTD
-37.1%
-37.1%
1 Month
-20.2%
-20.2%
3 Month
-43.6%
-43.6%
6 Month
-35.5%
-35.5%
1 Year
-43.0%
-43.0%
More News
Read More
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
December 05, 2025
Via
ACCESS Newswire
Let's take a look at the stocks that are in motion in today's session.
↗
December 04, 2025
Via
Chartmill
Disrupting a $6 Billion Skin Cancer Market: The Small-Cap Biotech (MDCX) Advancing a Non-Surgical Patch
December 04, 2025
Via
AB Newswire
Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President
December 01, 2025
Via
ACCESS Newswire
Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers
November 24, 2025
From
Medicus Pharma Ltd.
Via
GlobeNewswire
Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
November 17, 2025
Via
ACCESS Newswire
Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
November 17, 2025
From
Medicus Pharma
Via
GlobeNewswire
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
November 14, 2025
Via
ACCESS Newswire
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
November 13, 2025
Via
ACCESS Newswire
Medicus Pharma Ltd. (NASDAQ: MDCX) and the Patch That Could End Repetitive Cancer Surgeries
November 05, 2025
Via
AB Newswire
Emerging Biotech Stars Poised for Multi-Billion-Dollar Breakthroughs (MDCX, ACTU, LTRN, TNXP)
October 30, 2025
Via
AB Newswire
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
October 29, 2025
Via
ACCESS Newswire
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome
October 29, 2025
From
Medicus Pharma
Via
GlobeNewswire
4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA)
October 23, 2025
Via
AB Newswire
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
October 22, 2025
Via
ACCESS Newswire
4 Diagnostic Stocks Targeting 25%+ Annual Growth in a $20B Market (MDCX, ILMN, EXAS, GH)
October 16, 2025
Via
AB Newswire
Three Biotech Companies Redefining Value Creation Through Dual Strategies
October 14, 2025
Via
ACCESS Newswire
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
October 13, 2025
Via
ACCESS Newswire
Medicus Pharma (Nasdaq: MDCX) Nears Surgery-Free Breakthrough in Oncology
October 10, 2025
Via
AB Newswire
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
October 07, 2025
Via
ACCESS Newswire
Medicus Pharma (Nasdaq: MDCX) Bringing Scar-Free, Outpatient Treatment to an $8 Billion Cancer Market
October 02, 2025
Via
AB Newswire
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
September 29, 2025
Via
ACCESS Newswire
Biotech Stocks Positioned to Transform Treatment With Next-Gen Therapeutics
September 26, 2025
Via
News Direct
Frequently Asked Questions
Is Medicus Pharma Ltd. - Common Stock publicly traded?
Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.
What exchange does Medicus Pharma Ltd. - Common Stock trade on?
Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?
The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market
What is the current price of Medicus Pharma Ltd. - Common Stock?
The current price of Medicus Pharma Ltd. - Common Stock is 1.580
When was Medicus Pharma Ltd. - Common Stock last traded?
The last trade of Medicus Pharma Ltd. - Common Stock was at 12/24/25 10:51 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
